https://www.bcm.edu/healthcare/clinical-trials/h-53936
MajesTEC-9: Teclistamab Monotherapy vs Pomalidomide, Bortezomib, Dexamethasone (PVd) or...
MajesTEC-9: A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib,...
bortezomib dexamethasone9teclistamabmonotherapyvs
https://www.jnj.com/media-center/press-releases/updated-results-from-the-phase-1-study-of-the-bcmaxcd3-bispecific-teclistamab-show-preliminary-efficacy-in-patients-with-heavily-pretreated-relapsed-or-refractory-multiple-myeloma
Updated Results from the Phase 1 Study of the BCMAxCD3 Bispecific Teclistamab Show Preliminary...
Nov 16, 2025 - First-reported results for the subcutaneous formulation and updated results for the intravenous formulation presented at ASH 2020
phase 1 study
https://www.jnj.com/innovativemedicine/emea/janssen-presents-first-data-phase-1-study-bcmaxcd3-bispecific-teclistamab-patients-heavily-pre
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with...
https://www.cancer.gov/research/participate/clinical-trials/intervention/teclistamab
Clinical Trials Using Teclistamab - NCI
NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying teclistamab.
clinical trialsusingteclistamabnci
https://www.ncbi.nlm.nih.gov/books/NBK501922/?term=TECLISTAMAB
TECLISTAMAB - Books - NCBI
teclistamabbooksncbi
https://www.uhhospitals.org/uh-research/find-clinical-trials-and-studies/clinical-trials-search/teclistamab-w-daratumumab-and-lenalidomide-tec-dr-in-participants-w-mm-23262
Teclistamab w/ Daratumumab and Lenalidomide (Tec-DR) in Participants w/ MM * | University Hospitals
A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab...
https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/prophylactic-tocilizumab-prior-outpatient-step-administration
Prophylactic Tocilizumab Before Outpatient Step-Up Administration of Teclistamab in Patients With...
Robert Rifkin, MD, shares results evaluating outpatient step-up administration of teclistamab among patients with R/R MM.
step up
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1664171/full
Frontiers | Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory...
Systemic light chain amyloidosis (AL) is an uncommon disorder of clonal plasma cells, marked by the creation of amyloid-forming immunoglobulin light chains t...
case report